Agitation: Clinical Trials

23 trials for Agitation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 4 unknown, 4 withdrawn, 1 not yet recruiting. 23 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 423Completed 14, Unknown 4, Withdrawn 4, Not yet recruiting 1

Follow Agitation: new trials by email Literature Review of Agitation trials Research Report on Agitation

Trials (filtered) newest first · largest first

All 23 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Esketamine - Dexmedetomidine Combination Versus Dexmedetomidine Monotherapy for Hyperactive Delirium in ICU Patients on Non-Invasive Respiratory Support (SEED-NIRS Trial): Study Protocol of a Randomized Controlled Trial
Esketamine combined with dexmedetomidine, Dexmedetomidine - Dexmedetomidine, Ketamine
Phase 4Not yet recruitingThe First Affiliated Hospital with Nanjing Medical University3562026-09-282026-09-03
Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department
Sublingual film containing dexmedetomidine (BXCL501) - Agitation, Schizophrenia
Phase 4WithdrawnBrigham and Women's Hospital2023-09-012026-01-28
Nalbuphine Versus Dexmedetomidine for Prevention of Emergence Agitation in Pediatrics
Nalbuphine, Dexmedetomidine, normal Saline - Agitation
Phase 4UnknownAlexandria University1262022-03-012022-04-08
Emergence Agitation After Nasal Surgery: a Randomized Controlled Comparison Between Melatonin and Mirtazapine
Mirtazapine, Melatonin, Placebo - Agitation
Phase 4CompletedAin Shams University1652021-06-152022-04-15
TREC-Lebanon: A Trial for Rapid Tranquilisation for Agitated Patients in the Emergency Setting
Haloperidol + Promethazine + Chlorpromazine, Haloperidol + Promethazine - Psychiatric Emergency, Aggression
Phase 4CompletedJoseph Dib1002018-08-282022-06-14
Phase IV to Evaluate the Safety of Self-administered ADASUVE® in Agitated Patients Outside the Hospital Setting
Staccato® Delivery System Loxapine (ADASUVE®) - Agitation
Phase 4CompletedFerrer Internacional S.A.3232016-09-082020-11-04
Comparison of Ketamine-propofol Combinations
Ketamine-propofol mixture - Agitation, Postoperative Pain
Phase 4CompletedCukurova University752016-07-012017-04-20
Scalp Nerve Block on Emergence Agitation
Ropivacaine, Remifentanil, Sevoflurane - Agitation
Phase 4CompletedAjou University School of Medicine442015-05-012017-01-25
Study of Sedative Medications in Patients With Severe Infection and Respiratory Failure
Propofol, Dexmedetomidine, Fentanyl - Sepsis, Respiratory Failure
Phase 4CompletedTexas Tech University Health Sciences Center362014-08-012020-03-02
Ketamine Versus Haloperidol for Severe Agitation Outside the Hospital
Ketamine, Haloperidol - Agitation
Phase 4WithdrawnHennepin Healthcare Research Institute2014-04-012017-07-24
Effect of Deksmedetomidine and Remifentanil in Extubation Agitation
deksmedetomidine, Remifentanil, Saline - Agitation
Phase 4UnknownDiskapi Yildirim Beyazit Education and Research Hospital902014-04-012014-04-04
Addition of Magnesium Sulfate to Caudal to Prevent Postoperative Emergence Agitation.
Magnesium Sulfate, 0.9%normal saline - Agitation, Pediatric Disorder
Phase 4UnknownAin Shams University702013-10-012014-06-17
Dexmedetomidine to Prevent Agitation After Free Flap Surgery
Dexmedetomidine, Saline placebo - Agitation, Delirium
Phase 4CompletedPeking University802013-06-012014-11-13
Treating Acutely Agitated Patients With Asenapine Sublingual Tablets
Asenapine, Placebo - Agitation
Phase 4CompletedUnity Health Toronto1202012-04-012016-05-16
Effect of Single-dose Dexmedetomidine on Emergence Excitement in Adults With Nasotracheal Intubation After Orthognathic Surgery
saline, Dexmedetomidine - Agitation
Phase 4CompletedYonsei University742011-10-012015-02-06
ED50 of Dexmedetomidine to Prevent Emergence Agitation in Children
Dexmedetomidine - Agitation
Phase 4UnknownSeoul National University Hospital252011-06-012011-06-16
Efficacy and Safety of Risperidone and Trazodone Monotherapy and Combination Therapy in Critically Ill Patients With Delirium
Risperidone, Trazodone, Placebo - Delirium, Agitation
Phase 4WithdrawnRochester General Hospital2011-03-012019-09-10
Ziprasidone vs Standard Therapy for Agitated Patients in the ED
ziprasidone, Standard therapy - Psychosis, Agitation
Phase 4WithdrawnGeorge Washington University2008-09-012017-09-25
Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to Risperidone
Escitalopram, Risperidone - Agitation, Psychosis
Phase 4CompletedAbarbanel Mental Health Center402008-04-012015-06-24
A Comparison Study of the Efficacy of Quetiapine and Haloperidol in Agitated Adults in Emergency Room
Quetiapine, Haloperidol, Lorazepam - Agitation
Phase 4CompletedUniversity of Southern California722006-05-012019-07-26

Showing 20 of 23. Sign in to see all of them.

Narrower conditions

Psychomotor Agitation (23)  ·  Psychotic Disorders (6)  ·  Alzheimer Disease (3)  ·  Delirium (3)  ·  Schizophrenia (3)  ·  Aggression (2)  ·  Bipolar Disorder (2)  ·  Agnosia (1)  ·  Dementia (1)  ·  Pain, Postoperative (1)  ·  Respiratory Insufficiency (1)  ·  Sepsis (1)

Broader conditions

Aberrant Motor Behavior in Dementia (23)  ·  Behavior (23)  ·  Behavioral Symptoms (23)  ·  Dyskinesias (23)  ·  Nervous System Diseases (23)  ·  Neurobehavioral Manifestations (23)  ·  Neurologic Manifestations (23)  ·  Pathological Conditions, Signs and Symptoms (23)  ·  Psychomotor Disorders (23)  ·  Signs and Symptoms (23)  ·  Mental Disorders (9)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (7)  ·  Neurocognitive Disorders (6)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)

Interventions

Dexmedetomidine (7)  ·  Haloperidol (4)  ·  Risperidone (4)  ·  Saline Solution (3)  ·  Sodium Chloride (3)  ·  Remifentanil (2)  ·  Benztropine (1)  ·  Chlorpromazine (1)  ·  Dexetimide (1)  ·  Escitalopram (1)  ·  Fentanyl (1)  ·  Fumigant 93 (1)  ·  Ketamine (1)  ·  Lorazepam (1)  ·  Magnesium Sulfate (1)

Sponsors

Ain Shams University (2)  ·  New York State Psychiatric Institute (2)  ·  Abarbanel Mental Health Center (1)  ·  Ajou University School of Medicine (1)  ·  Alexandria University (1)  ·  Brigham and Women's Hospital (1)  ·  Cukurova University (1)  ·  Diskapi Yildirim Beyazit Education and Research Hospital (1)  ·  Ferrer Internacional S.A. (1)  ·  George Washington University (1)  ·  Hennepin Healthcare Research Institute (1)  ·  Joseph Dib (1)  ·  Peking University (1)  ·  Rochester General Hospital (1)  ·  Seoul National University Hospital (1)

Countries

United States (8)  ·  Egypt (3)  ·  South Korea (3)  ·  China (2)  ·  Turkey (Türkiye) (2)  ·  Israel (1)  ·  Lebanon (1)  ·  Spain (1)

Top investigators

Alaa Elkateb, MD (1)  ·  Davangere Devanand, M.D. (1)  ·  Davangere P. Devanand, MD (1)  ·  David Frey, MD (1)  ·  Gabrielle A Carlson, MD (1)  ·  George M Simpson, MD (1)  ·  Hee-Soo Kim, M.D, PhD (1)  ·  Jong Yeop Kim, MD (1)  ·  Kenneth Nugent, MD (1)  ·  Laura Leso, MD (1)  ·  Michael J Pratts, MD (1)  ·  Mindee S Hite, Pharm.D. (1)  ·  Reyhan Polat, MD (1)  ·  Thais B Teixeira, PharmD, PhD (1)

Results publications

PMID 21845596, PMID 23075176, PMID 24606117, PMID 27855483, PMID 29249041, PMID 30282677, PMID 32528650

NIH funding

R01AG021488 (1), R01MH055735 (1)